Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin

по Slingluff Craig L, Brautigan David L, Molhoek Kerrington R
Опубликовано 2005-10-01

Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin

по Molhoek, Kerrington R, Brautigan, David L, Slingluff, Craig L
Опубликовано 2005

Interface of Signal Transduction Inhibition and Immunotherapy in Melanoma

по Shada, Amber L., Molhoek, Kerrington R., Slingluff, Craig L.
Опубликовано 2010

Apoptosis of CD4(+)CD25(high) T cells in response to Sirolimus requires activation of T Cell Receptor and is modulated by IL-2

по Molhoek, Kerrington R., McSkimming, Chantel C., Olson, Walter C., Brautigan, David L., Slingluff, Craig L.
Опубликовано 2008

Human melanoma cytolysis by combined inhibition of mTOR and VEGF/VEGFR-2

по Molhoek, Kerrington R., Griesemann, Heinrich, Shu, Jianfen, Gershenwald, Jeffrey E., Brautigan, David L., Slingluff, Craig L.
Опубликовано 2008

Comprehensive analysis of RTK activation in human melanomas reveals autocrine signaling through IGF-1R

по Molhoek, Kerrington R., Shada, Amber L., Smolkin, Mark, Chowbina, Sudhir, Papin, Jason, Brautigan, David L., Slingluff, Craig L.
Опубликовано 2011

Evaluation of Molecular Markers of Mesenchymal Phenotype in Melanoma

по Mikesh, Leann M., Kumar, Manish, Erdag, Gulsun, Hogan, Kevin T., Molhoek, Kerrington R., Mayo, Marty W., Slingluff, Craig L.
Опубликовано 2010

VEGFR-2 Expression in Human Melanoma: Revised Assessment

по Molhoek, Kerrington R., Erdag, Gulsun, Rasamny, Jk, Murphy, Cheryl, Deacon, Donna, Patterson, James W., Slingluff, Craig L., Brautigan, David L.
Опубликовано 2011

MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and Bevacizumab

по Wagenseller, Aubrey G, Shada, Amber, D’Auria, Kevin M, Murphy, Cheryl, Sun, Dandan, Molhoek, Kerrington R, Papin, Jason A, Dutta, Anindya, Slingluff Jr, Craig L
Опубликовано 2013

The vaccine-site microenvironment induced by injection of incomplete Freund's adjuvant, with or without melanoma peptides

по Harris, Rebecca C., Chianese-Bullock, Kimberly A., Petroni, Gina R., Schaefer, Jochen T., Brill, Louis B., Molhoek, Kerrington R., Deacon, Donna H., Patterson, James W., Slingluff, Craig L.
Опубликовано 2012

Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: A Phase II trial (CTEP 7190/Mel47)

по Slingluff, Craig L., Petroni, Gina R, Molhoek, Kerrington R., Brautigan, David L., Chianese-Bullock, Kimberly A., Shada, Amber L., Smolkin, Mark E., Olson, Walter C., Gaucher, Alison, Chase, Cheryl Murphy, Grosh, William W., Weiss, Geoffrey R., Wagenseller, Aubrey G., Olszanski, Anthony J., Martin, Lainie, Shea, Sofa M., Erdag, Gulsun, Ram, Prahlad, Gershenwald, Jeffrey E., Weber, Michael J.
Опубликовано 2013